19.59
price up icon0.05%   0.01
after-market アフターアワーズ: 19.59
loading
前日終値:
$19.58
開ける:
$19.57
24時間の取引高:
421.02K
Relative Volume:
0.43
時価総額:
$622.57M
収益:
$17.16M
当期純損益:
$-163.62M
株価収益率:
-3.222
EPS:
-6.08
ネットキャッシュフロー:
$-121.61M
1週間 パフォーマンス:
-7.55%
1か月 パフォーマンス:
+15.92%
6か月 パフォーマンス:
-8.07%
1年 パフォーマンス:
-25.31%
1日の値動き範囲:
Value
$19.09
$20.04
1週間の範囲:
Value
$18.51
$21.52
52週間の値動き範囲:
Value
$12.21
$41.31

Anaptysbio Inc Stock (ANAB) Company Profile

Name
名前
Anaptysbio Inc
Name
セクター
Healthcare (1153)
Name
電話
858-362-6295
Name
住所
10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA
Name
職員
136
Name
Twitter
@anaptysbio
Name
次回の収益日
2024-11-08
Name
最新のSEC提出書
Name
ANAB's Discussions on Twitter

ANAB を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ANAB
Anaptysbio Inc
19.59 622.57M 17.16M -163.62M -121.61M -6.08
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
424.99 128.84B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
527.78 65.38B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ARGX
Argen X Se Adr
549.65 39.67B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
251.15 33.82B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ONC
Beigene Ltd Adr
231.99 27.60B 3.81B -644.79M -669.77M -6.24

Anaptysbio Inc Stock (ANAB) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-02-04 開始されました Wolfe Research Outperform
2024-12-11 ダウングレード H.C. Wainwright Buy → Neutral
2024-12-02 ダウングレード BTIG Research Buy → Neutral
2024-07-22 開始されました H.C. Wainwright Buy
2024-07-19 アップグレード JP Morgan Neutral → Overweight
2024-04-16 開始されました Leerink Partners Outperform
2024-04-11 開始されました Wells Fargo Overweight
2024-03-12 アップグレード Wedbush Neutral → Outperform
2024-02-26 開始されました BTIG Research Buy
2024-02-21 開始されました Stifel Buy
2024-02-16 開始されました Piper Sandler Overweight
2023-05-22 アップグレード JP Morgan Underweight → Neutral
2023-05-18 開始されました TD Cowen Outperform
2023-01-06 ダウングレード Raymond James Outperform → Mkt Perform
2022-11-01 アップグレード Guggenheim Neutral → Buy
2022-09-19 再開されました H.C. Wainwright Buy
2022-09-13 ダウングレード Truist Buy → Hold
2022-09-01 開始されました Raymond James Outperform
2022-03-22 ダウングレード Guggenheim Buy → Neutral
2021-06-22 開始されました H.C. Wainwright Buy
2021-05-21 開始されました UBS Neutral
2021-03-16 アップグレード Truist Hold → Buy
2021-03-09 ダウングレード Wedbush Outperform → Neutral
2021-03-08 ダウングレード JP Morgan Overweight → Underweight
2021-02-11 アップグレード JP Morgan Underweight → Overweight
2020-10-27 アップグレード Wedbush Neutral → Outperform
2020-10-14 アップグレード Guggenheim Neutral → Buy
2019-11-08 ダウングレード JP Morgan Overweight → Underweight
2019-11-08 ダウングレード Jefferies Buy → Hold
2019-11-08 ダウングレード SunTrust Buy → Hold
2019-11-08 ダウングレード Wedbush Outperform → Neutral
2019-06-21 ダウングレード Credit Suisse Outperform → Neutral
2019-06-21 ダウングレード Stifel Buy → Hold
2018-12-20 開始されました H.C. Wainwright Buy
2018-11-21 開始されました JP Morgan Overweight
2018-07-19 開始されました Credit Suisse Outperform
2018-04-04 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2018-03-27 繰り返されました Stifel Buy
2018-03-06 繰り返されました Stifel Buy
2018-02-15 繰り返されました SunTrust Buy
2018-01-23 繰り返されました Credit Suisse Outperform
2017-11-15 開始されました SunTrust Buy
2017-11-09 開始されました Jefferies Buy
2017-10-11 繰り返されました RBC Capital Mkts Outperform
2017-09-15 開始されました RBC Capital Mkts Outperform
すべてを表示

Anaptysbio Inc (ANAB) 最新ニュース

pulisher
02:54 AM

Susquehanna Fundamental Investments LLC Invests $593,000 in AnaptysBio, Inc. (NASDAQ:ANAB) - MarketBeat

02:54 AM
pulisher
May 08, 2025

AnaptysBio, Inc. (NASDAQ:ANAB) Shares Sold by Invesco Ltd. - MarketBeat

May 08, 2025
pulisher
May 08, 2025

Barclays PLC Buys 39,267 Shares of AnaptysBio, Inc. (NASDAQ:ANAB) - MarketBeat

May 08, 2025
pulisher
May 08, 2025

AnaptysBio (NASDAQ:ANAB) Price Target Raised to $54.00 at Guggenheim - MarketBeat

May 08, 2025
pulisher
May 08, 2025

Earnings Update: AnaptysBio, Inc. (NASDAQ:ANAB) Just Reported And Analysts Are Boosting Their Estimates - simplywall.st

May 08, 2025
pulisher
May 08, 2025

Analysts Are Upgrading AnaptysBio, Inc. (NASDAQ:ANAB) After Its Latest Results - Yahoo Finance

May 08, 2025
pulisher
May 07, 2025

AnaptysBio (NASDAQ:ANAB) Releases Quarterly Earnings Results, Beats Expectations By $0.02 EPS - MarketBeat

May 07, 2025
pulisher
May 07, 2025

Is AnaptysBio (NASDAQ:ANAB) Using Debt Sensibly? - simplywall.st

May 07, 2025
pulisher
May 07, 2025

AnaptysBio First Quarter 2025 Earnings: Beats Expectations - Yahoo Finance

May 07, 2025
pulisher
May 07, 2025

Boxer Capital Management LLC Purchases New Shares in AnaptysBio, Inc. (NASDAQ:ANAB) - MarketBeat

May 07, 2025
pulisher
May 07, 2025

Nebula Research & Development LLC Makes New $231,000 Investment in AnaptysBio, Inc. (NASDAQ:ANAB) - MarketBeat

May 07, 2025
pulisher
May 07, 2025

AnaptysBio (ANAB) Expected to Announce Quarterly Earnings on Thursday - MarketBeat

May 07, 2025
pulisher
May 06, 2025

AnaptysBio Inc (ANAB) Q1 2025 Earnings: Revenue Surges to $27.8M - GuruFocus

May 06, 2025
pulisher
May 06, 2025

AnaptysBio Inc (ANAB) Q1 2025 Earnings: Revenue Surges to $27.8M, Beating Estimates; EPS at -$1.28, Slightly Below Expectations - GuruFocus

May 06, 2025
pulisher
May 06, 2025

Forecasting The Future: 6 Analyst Projections For AnaptysBio - Benzinga

May 06, 2025
pulisher
May 06, 2025

AnaptysBio (ANAB) Price Target Raised by Guggenheim | ANAB Stock News - GuruFocus

May 06, 2025
pulisher
May 06, 2025

AnaptysBio (ANAB) Price Target Increased Amid Promising Clinical Developments | ANAB Stock News - GuruFocus

May 06, 2025
pulisher
May 05, 2025

AnaptysBio, Inc. (ANAB) Tops Q1 EPS by 2c - StreetInsider

May 05, 2025
pulisher
May 05, 2025

AnaptysBio, Inc. (ANAB) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance

May 05, 2025
pulisher
May 05, 2025

AnaptysBio (ANAB) Surpasses Revenue Expectations with Strong Q1 Performance | ANAB Stock News - GuruFocus

May 05, 2025
pulisher
May 05, 2025

Anaptys Announces First Quarter 2025 Financial Results and Provides Business Update | ANAB Stock News - GuruFocus

May 05, 2025
pulisher
May 05, 2025

ANAPTYSBIO, INC SEC 10-Q Report - TradingView

May 05, 2025
pulisher
May 05, 2025

Anaptys Announces First Quarter 2025 Financial Results and Provides Business Update - GlobeNewswire

May 05, 2025
pulisher
May 05, 2025

BRIEF-AnaptysBio Q1 Net Income USD -39.329 Million - TradingView

May 05, 2025
pulisher
May 05, 2025

Anaptys Breakthrough: Rosnilimab Shows Strong Phase 2b Results in RA, Multiple Pipeline Catalysts Ahead - Stock Titan

May 05, 2025
pulisher
May 03, 2025

First Light Asset Management LLC Has $11.50 Million Stake in AnaptysBio, Inc. (NASDAQ:ANAB) - MarketBeat

May 03, 2025
pulisher
May 03, 2025

Wedbush Reaffirms “Outperform” Rating for AnaptysBio (NASDAQ:ANAB) - Defense World

May 03, 2025
pulisher
May 02, 2025

AnaptysBio, Inc. (NASDAQ:ANAB) Shares Purchased by Geode Capital Management LLC - MarketBeat

May 02, 2025
pulisher
May 02, 2025

JPMorgan Chase & Co. Has $1.52 Million Position in AnaptysBio, Inc. (NASDAQ:ANAB) - MarketBeat

May 02, 2025
pulisher
May 02, 2025

AnaptysBio Gears Up For Key Trial Readouts In Rheumatoid Arthritis And Lung Cancer - RTTNews

May 02, 2025
pulisher
May 01, 2025

AnaptysBio (ANAB) Stock Maintains Outperform Rating with $40 Pri - GuruFocus

May 01, 2025
pulisher
May 01, 2025

AnaptysBio (ANAB) Stock Maintains Outperform Rating with $40 Price Target | ANAB Stock News - GuruFocus

May 01, 2025
pulisher
May 01, 2025

Alopecia Areata Pipeline 2025: FDA Updates, Therapy Innovations, and Clinical Trial Landscape Analysis by DelveInsight | Pfizer, Legacy Healthcare, AnaptysBio, Eli Lilly and Company, Incyte Corp - Barchart.com

May 01, 2025
pulisher
May 01, 2025

What is the investor’s view on AnaptysBio Inc (ANAB)? - uspostnews.com

May 01, 2025
pulisher
May 01, 2025

A company insider recently bought 65,184 shares of AnaptysBio Inc [ANAB]. Should You Buy? - knoxdaily.com

May 01, 2025
pulisher
May 01, 2025

AnaptysBio (NASDAQ:ANAB) versus Endonovo Therapeutics (OTCMKTS:ENDVD) Head-To-Head Comparison - Defense World

May 01, 2025
pulisher
Apr 30, 2025

(ANAB) Investment Analysis and Advice - news.stocktradersdaily.com

Apr 30, 2025
pulisher
Apr 28, 2025

Investor’s Delight: AnaptysBio Inc (ANAB) Closes Weak at 18.59, Down -1.90 - DWinneX

Apr 28, 2025
pulisher
Apr 28, 2025

Gaining Ground: AnaptysBio Inc (ANAB) Closes Lower at 16.34, Down -0.37 - DWinneX

Apr 28, 2025
pulisher
Apr 27, 2025

AnaptysBio, Inc. (NASDAQ:ANAB) Shares Bought by Russell Investments Group Ltd. - Defense World

Apr 27, 2025
pulisher
Apr 26, 2025

AnaptysBio, Inc. (NASDAQ:ANAB) Shares Acquired by Geode Capital Management LLC - Defense World

Apr 26, 2025
pulisher
Apr 26, 2025

JPMorgan Chase & Co. Raises Holdings in AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World

Apr 26, 2025
pulisher
Apr 25, 2025

XTX Topco Ltd Buys 19,727 Shares of AnaptysBio, Inc. (NASDAQ:ANAB) - MarketBeat

Apr 25, 2025
pulisher
Apr 24, 2025

AnaptysBio Inc (ANAB) Stock: A Comprehensive 52-Week Review - investchronicle.com

Apr 24, 2025
pulisher
Apr 24, 2025

What was AnaptysBio Inc (ANAB)’s performance in the last session? - uspostnews.com

Apr 24, 2025
pulisher
Apr 24, 2025

Gaining Ground: AnaptysBio Inc (ANAB) Closes Lower at 20.42, Down -5.38 - DWinneX

Apr 24, 2025
pulisher
Apr 24, 2025

ANAB Stock Sees Surge of Approximately 12.82% in Last Five Days - knoxdaily.com

Apr 24, 2025
pulisher
Apr 22, 2025

AnaptysBio, Inc. (NASDAQ:ANAB) Shares Sold by Federated Hermes Inc. - MarketBeat

Apr 22, 2025

Anaptysbio Inc (ANAB) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$65.08
price down icon 0.84%
$19.36
price down icon 0.31%
$33.15
price up icon 0.15%
$23.96
price down icon 2.80%
$92.77
price down icon 2.12%
biotechnology ONC
$231.99
price down icon 1.67%
大文字化:     |  ボリューム (24 時間):